Single or Dual Antiplatelet Therapy Improves One-Year Arteriovenous Graft Patency and Overall Survival

Following new dialysis access creation there is no consensus on the optimal anti-thrombotic therapy. Recent studies have shown that single antiplatelet therapy may improve hospital mortality and patency. The aim of this study was to assess the role of different anti-thrombotic therapies on outcomes following access creation.

Source: Annals of Vascular Surgery - February 15, 2024 Category: Surgery Authors: David P. Ebertz, Saideep Bose, Armando De Valle, Satinderjit Locham, Mahmoud B. Malas Malas, Matthew R. Smeds Source Type: research